Showing 20 of 96 recruiting trials for “cystic-fibrosis”
ACT With CF Self-Help Toolkit
RecruitingNCT07083557 ↗
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
👨⚕️ Bettina Mittendorfer, PhD, University of Missouri-Columbia📍 1 site📅 Started Jan 2026View details ↗
RecruitingNCT07369414 ↗
Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at Home
👨⚕️ Alexander Mischnik, Prof. Dr. med., National and WHO-Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center📍 2 sites📅 Started Jan 2026View details ↗
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
RecruitingNCT07363304 ↗
Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.
Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta
RecruitingNCT07245407 ↗
A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
👨⚕️ Jinfu Xu, Doctor, Shanghai Tongji Hospital, Tongji University School of Medicine📍 38 sites📅 Started Oct 2025View details ↗
RecruitingNCT07342920 ↗
Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis
Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis
RecruitingNCT07333612 ↗
IM Bands in Inactive Hepatic CE
RecruitingNCT06837181 ↗
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
👨⚕️ Philip Ryan, MBBS, BMedSc, PhD, DPM, FFPM, Nucleus Network📍 2 sites📅 Started Jul 2025View details ↗
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
RecruitingNCT06797206 ↗
A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring
👨⚕️ Imogen Felton, Royal Brompton Hospital and NHLI Imperial College London📍 1 site📅 Started Jun 2025View details ↗
Ensuring Access to Optimal Therapy in CF: The ENACT Study
👨⚕️ Jennifer S Guimbellot, Medical Degree and License, Arkansas Children's Hospital Research Institute📍 2 sites📅 Started Jun 2025View details ↗
The School-Age Children With Cystic Fibrosis and Their Parents on Health Literacy
RecruitingNCT07048574 ↗
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
Clean Air for Rare MUcociliary Clearance dIsorders
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →